Bio-reduction of Redox-Sensitive Albumin Conjugates in FcRn-Expressing Cells

被引:16
作者
Bruelisauer, Lorine [1 ]
Valentino, Gina [1 ]
Morinaga, Sakura [1 ]
Cam, Kuebra [1 ]
Bukrinski, Jens Thostrup [3 ]
Gauthier, Marc A. [2 ]
Leroux, Jean-Christophe [1 ]
机构
[1] Swiss Fed Inst Technol Zurich ETHZ, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
[2] EMT Res Ctr, INRS, Varennes, PQ J3X 1S2, Canada
[3] Novozymes AS, DK-2880 Bagsvaerd, Denmark
关键词
albumin; disulfide; drug delivery; FcRn receptors; reduction; SURFACE THIOLS; DRUG-DELIVERY; HALF-LIFE; IGG; PHARMACOKINETICS; MECHANISM; RECEPTOR; PROTEIN; DEGRADATION; ANTIBODIES;
D O I
10.1002/anie.201404238
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Disulfide-containing IgG-, Fc-, or albumin-based prodrugs that rely on FcRn-trafficking by endothelial cells for prolonged circulation in the body might be hampered by premature bio-reduction processes during FcRn-mediated recycling events. A detailed bio-reduction analysis of redox-sensitive albumin conjugates in two FcRn-expressing cell lines has been performed. The obtained results indicate that the FcRn-mediated recycling pathway is not (or is only poorly) bio-reducing.
引用
收藏
页码:8392 / 8396
页数:5
相关论文
共 45 条
[1]   Antibody-drug conjugates: targeted drug delivery for cancer [J].
Alley, Stephen C. ;
Okeley, Nicole M. ;
Senter, Peter D. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (04) :529-537
[2]   Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor [J].
Andersen, Jan Terje ;
Dalhus, Bjorn ;
Cameron, Jason ;
Daba, Muluneh Bekele ;
Plumridge, Andrew ;
Evans, Leslie ;
Brennan, Stephan O. ;
Gunnarsen, Kristin Stoen ;
Bjoras, Magnar ;
Sleep, Darrell ;
Sandlie, Inger .
NATURE COMMUNICATIONS, 2012, 3
[3]   The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics [J].
Andersen, Jan Terje ;
Sandlie, Inger .
DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (04) :318-332
[4]   Cell-surface thiols affect cell entry of disulfide-conjugated peptides [J].
Aubry, Soline ;
Burlina, Fabienne ;
Dupont, Edmond ;
Delaroche, Diane ;
Joliot, Alain ;
Lavielle, Solange ;
Chassaing, Gerard ;
Sagan, Sandrine .
FASEB JOURNAL, 2009, 23 (09) :2956-2967
[5]   Delivery of Nucleic Acids via Disulfide-Based Carrier Systems [J].
Bauhuber, Sonja ;
Hozsa, Constantin ;
Breunig, Miriam ;
Goepferich, Achim .
ADVANCED MATERIALS, 2009, 21 (32-33) :3286-3306
[6]   3-(N-MALEIMIDO-PROPIONYL) BIOCYTIN - A VERSATILE THIOL-SPECIFIC BIOTINYLATING REAGENT [J].
BAYER, EA ;
ZALIS, MG ;
WILCHEK, M .
ANALYTICAL BIOCHEMISTRY, 1985, 149 (02) :529-536
[7]   Tracking the Bioreduction of Disulfide-Containing Cationic Dendrimers [J].
Bruelisauer, Lorine ;
Kathriner, Nadia ;
Prenrecaj, Mark ;
Gauthier, Marc A. ;
Leroux, Jean-Christophe .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (50) :12454-12458
[8]  
Brulisauer L., 2012, ANGEW CHEM, V124, P12622
[9]  
Chari R. V. J., 2014, ANGEW CHEM, V126, P3872
[10]   Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy [J].
Chari, Ravi V. J. ;
Miller, Michael L. ;
Widdison, Wayne C. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (15) :3796-3827